● Recruiting

KOrean Borderline Ovarian Tumor (KOBOT) Registry

Condition: Ovarian Neoplasms · Sponsor: Kangbuk Samsung Hospital

PhaseN/A

Planned participants3000

Who can joinFemale, N/A to no upper limit

Healthy volunteersNo

About this study

The aim of this study is to collect data on Korean patients with borderline ovarian tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Taejong Song, MD,PhD · 82-2-2001-2582 · taejong.song@gmail.com

Always discuss trial participation with your own doctor first.

Locations (4)

Samsung Changwon Hospital	Changwon, South Korea	Recruiting
Kangbuk Samsung Hospital	Seoul, South Korea	Recruiting
CHA Gangnam Medical Center	Seoul, South Korea	Recruiting
Samsung Medical Center	Seoul, South Korea	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02803970